ATE507309T1 - Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung - Google Patents
Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückungInfo
- Publication number
- ATE507309T1 ATE507309T1 AT09151217T AT09151217T ATE507309T1 AT E507309 T1 ATE507309 T1 AT E507309T1 AT 09151217 T AT09151217 T AT 09151217T AT 09151217 T AT09151217 T AT 09151217T AT E507309 T1 ATE507309 T1 AT E507309T1
- Authority
- AT
- Austria
- Prior art keywords
- cell carcinoma
- oral squamous
- suppressing
- carcinoma
- detecting
- Prior art date
Links
- 208000000102 Squamous Cell Carcinoma of Head and Neck Diseases 0.000 title abstract 5
- 201000002740 oral squamous cell carcinoma Diseases 0.000 title abstract 5
- 201000009030 Carcinoma Diseases 0.000 abstract 3
- 108091070501 miRNA Proteins 0.000 abstract 3
- 239000002679 microRNA Substances 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 206010064912 Malignant transformation Diseases 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000036212 malign transformation Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008012256A JP5116026B2 (ja) | 2008-01-23 | 2008-01-23 | 癌の検出方法および癌抑制剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE507309T1 true ATE507309T1 (de) | 2011-05-15 |
Family
ID=40748687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT09151217T ATE507309T1 (de) | 2008-01-23 | 2009-01-23 | Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20090202624A1 (de) |
| EP (1) | EP2088208B1 (de) |
| JP (1) | JP5116026B2 (de) |
| AT (1) | ATE507309T1 (de) |
| DE (1) | DE602009001116D1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5567555B2 (ja) * | 2009-04-16 | 2014-08-06 | 学校法人慶應義塾 | 頭頸部腫瘍増殖抑制剤 |
| EP2283846A1 (de) | 2009-08-12 | 2011-02-16 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | miRNA-Verbindungen zur Behandlung von Prostatakarzinomen |
| JP5812491B2 (ja) * | 2009-10-01 | 2015-11-11 | 国立研究開発法人国立がん研究センター | 腫瘍治療剤 |
| WO2011067346A1 (en) * | 2009-12-04 | 2011-06-09 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Method for determining the efficiency of a cancer treatment |
| EP2594275B1 (de) | 2010-07-08 | 2016-05-11 | Takeda Pharmaceutical Company Limited | Prophylaktischer oder therapeutischer wirkstoff gegen diabetes |
| US20130237456A1 (en) * | 2011-05-06 | 2013-09-12 | Jia Fan | Marker consisting of plasma microrna and a new method for diagnosis of hepatocellular carcinoma |
| JPWO2013038737A1 (ja) | 2011-09-16 | 2015-03-23 | Lsipファンド運営合同会社 | 膀胱癌細胞の検出方法、膀胱癌細胞の検出方法に用いるプライマー及び膀胱癌マーカ |
| WO2013071502A1 (en) * | 2011-11-17 | 2013-05-23 | Genedia Biotech Co Ltd | Mir-193a-3p and associated genes predict tumorigenesis and chemotherapy outcomes |
| EP3369818B1 (de) * | 2011-12-22 | 2021-06-09 | InteRNA Technologies B.V. | Mirna zur behandlung von kopf-hals-karzinom |
| EP2963125B1 (de) * | 2013-02-15 | 2020-09-30 | National University Corporation Tokyo Medical and Dental University | Therapeutisches mittel zur behandlung eines krebses, in dem nrf2 stabilisiert ist |
| WO2017079571A1 (en) * | 2015-11-05 | 2017-05-11 | Arphion Diagnostics | Process for the indentication of patients at risk for oscc |
| KR20240158357A (ko) * | 2017-11-09 | 2024-11-04 | 가부시키가이샤 팜엑스 테라퓨틱스 | miRNA를 포함하는 암 치료용 의약 조성물 |
| US20210071259A1 (en) * | 2017-12-13 | 2021-03-11 | Hiroshima University | Method for assisting detection of head and neck cancer |
| WO2020245822A1 (en) * | 2019-06-03 | 2020-12-10 | Carmel Haifa University Economic Corporation Ltd. | Human head and neck cancer treatment |
| TWI917330B (zh) | 2019-08-09 | 2026-03-11 | 日商Ube股份有限公司 | 胞外體的產生方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1713938A2 (de) | 2004-02-09 | 2006-10-25 | Thomas Jefferson University | Diagnose und behandlung von krebserkrankungen mit oder nahe mit krebs in zusammenhang stehenden chromosomalen merkmalen lokalisierter microrna |
| ES2534300T3 (es) | 2004-11-12 | 2015-04-21 | Asuragen, Inc. | Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN |
| AU2007205234B2 (en) * | 2006-01-05 | 2012-07-12 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
| EP2484782B1 (de) * | 2006-01-05 | 2015-11-18 | The Ohio State University Research Foundation | Verfahren und Zusammensetzungen auf Mikro-RNA-Basis zur Diagnose und Behandlung von soliden Krebs |
| WO2007126150A1 (ja) * | 2006-04-27 | 2007-11-08 | National University Corporation Nagoya University | 癌の新規治療用組成物 |
| ES2425387T3 (es) * | 2006-07-13 | 2013-10-15 | The Ohio State University Research Foundation | Mir-106a para diagnosticar adenocarcinoma de colon de pronóstico de supervivencia pobre |
-
2008
- 2008-01-23 JP JP2008012256A patent/JP5116026B2/ja active Active
-
2009
- 2009-01-22 US US12/357,894 patent/US20090202624A1/en not_active Abandoned
- 2009-01-23 DE DE602009001116T patent/DE602009001116D1/de active Active
- 2009-01-23 EP EP09151217A patent/EP2088208B1/de active Active
- 2009-01-23 AT AT09151217T patent/ATE507309T1/de not_active IP Right Cessation
-
2010
- 2010-12-09 US US12/964,464 patent/US8183223B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20110076768A1 (en) | 2011-03-31 |
| JP5116026B2 (ja) | 2013-01-09 |
| EP2088208B1 (de) | 2011-04-27 |
| US8183223B2 (en) | 2012-05-22 |
| JP2009171876A (ja) | 2009-08-06 |
| US20090202624A1 (en) | 2009-08-13 |
| DE602009001116D1 (de) | 2011-06-09 |
| EP2088208A1 (de) | 2009-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602009001116D1 (de) | Verfahren zur Erkennung eines oralen Plattenepithelkarzinoms und Mittel zu dessen Unterdrückung | |
| ATE522627T1 (de) | Verfahren zur herstellung von nukleinsäuresonden | |
| DE602007002090D1 (de) | Verfahren zur Erkennung von anaplastischem Schilddrüsenkrebs, und Verfahren zur seiner Unterdrückung | |
| EP3862439A3 (de) | Leberkrebsdetektionskit oder -vorrichtung und detektionsverfahren | |
| EP4461824A3 (de) | Kit oder vorrichtung zur erkennung von gallengangkrebs und nachweisverfahren | |
| EP2262911A4 (de) | Zusammensetzungen, verfahren und kits mit synthetischen sonden zum nachweis der anwesenheit einer target-nukleinsäure | |
| DK3581662T3 (da) | Sammensætninger og fremgangsmåder til detektering og identificering af nukleinsyresekvenser i biologiske prøver | |
| WO2011055916A3 (ko) | 장암 진단을 위한 장암 특이적 메틸화 마커 유전자의 메틸화 검출방법 | |
| WO2011141908A3 (en) | Fluids testing apparatus and methods of use | |
| EP2402423A4 (de) | An monoterpenbestandteilen reiches ätherisches öl, verfahren zu seiner herstellung und verfahren zur sanierung von umweltschadstoffen anhand des ätherischen öls | |
| EP2547809A4 (de) | Verfahren, sondensets und kits zur erkennung der zerstörung von tumorunterdrückergenen durch in-situ-fluoreszenz-hybridisierung | |
| WO2008054556A3 (en) | Methods and compositions for detection of a target nucleic acid sequence | |
| WO2013106844A3 (en) | Methods and compositions for the treatment and diaginosis of pancreatic cancer | |
| WO2013102108A3 (en) | Nucleic acid hybridization probes | |
| DE602008006254D1 (de) | Doppel-oligonukleotid-nukleinsäurenachweisverfahren | |
| EP2518158A4 (de) | Marker für pankreaskarzinom, nachweisverfahren, kits und biochips dafür | |
| ATE533838T1 (de) | Verfahren zur verbesserten einführung von dna in bakterienzellen | |
| WO2009149319A3 (en) | Gene expression profiles associated with asthma exacerbation attacks | |
| MY160850A (en) | Polymer-bonded perylene dyes and compositions containing same | |
| AT10182U3 (de) | Verfahren zur überwachung von leistungsprüfständen, sowie leistungsprüfstand | |
| PH12017500798A1 (en) | Pna probes, kits and methods for detecting human papillomavirus genotypes of human papillomavirus | |
| MX363880B (es) | Sondas, cebadores cooperativos y aplicaciones de ellos. | |
| WO2019094780A3 (en) | Non-coding rna for detection of cancer | |
| EP2504348A4 (de) | Verfahren, reagenzien und kits für den nachweis von nukleinsäuremolekülen | |
| ATE544070T1 (de) | Verfahren zum nachweis von tumorspezifischen fusionsproteinen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |